Cytogenetic damage and genetic variants in the individuals susceptible to arsenic-induced cancer through drinking water

International Journal of Cancer

Volumn 118, Issue 10, 2006, Pages 2470-2478

  Ghosh, Pritha ^a   Basu, Anamika ^a   Mahata, Julie ^a   Basu, Sreemanti ^a   Sengupta, Mainak ^a   Das, Jayanta K ^b   Mukherjee, Angshuman ^c   Sarkar, Ajoy K ^d   Mondal, Lakshmikanta ^e   Ray, Kunal ^a   Giri, Ashok K ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b West Bank Hospital   (India)

^c VIVEKANANDA INSTITUTE OF MEDICAL SCIENCES   (India)

^d PEERLESS HOSPITAL   (India)

^e MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Arsenic; Cytogenetic damage; GSTM1; GSTP1; GSTT1; Skin lesions

Indexed keywords

ARSENIC; DRINKING WATER;

ADOLESCENT; ADULT; AGED; ARSENIC POISONING; ARTICLE; CHEMICAL CARCINOGENESIS; CHROMOSOME ABERRATION; CONFIDENCE INTERVAL; CYTOGENETICS; FEMALE; GENETIC VARIABILITY; GENOTOXICITY; HUMAN; INDIA; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MICRONUCLEUS; MOUTH MUCOSA; NULL ALLELE; POLYMERASE CHAIN REACTION; POPULATION EXPOSURE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SKIN CANCER; SOCIOECONOMICS; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; UROTHELIUM;

ADOLESCENT; ADULT; AGED; ARSENIC; DNA DAMAGE; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; INDIA; MALE; MIDDLE AGED; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; SKIN DISEASES; SOCIAL CLASS; VARIATION (GENETICS); WATER SUPPLY;

EID: 33646429496     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21640     Document Type: Article

References (57)

1. WHO. Guidelines for drinking water quality,2nd ed, vol.2:Health criteria and other supporting information. Geneva: WHO, 1996.940-94.
2. US EPA. Arsenic and clarifications to compliance and new source monitoring rule: a quick reference guide, 2001. Available at www. epa.gov/safewater/ars/quickguide.pdf (accessed August 14, 2003).
3. Chakraborti D, Rahman MM, Paul K, Chowdhury UK, Sengupta MK, Lodh D, Chanda CR, Saha KC, Mukherjee SC. Arsenic calamity in the Indian subcontinent-what lessons have been learned? Talanta 2002;58:3-22.
4. Guha Mazumder DN, Haque R, Ghosh N, De BK, Santra A, Chakraborty D, Smith AH. Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int J Epidemiol 1998;27:871-7.
5. Agahian B, Lee JS, Nelson JH, Johns RE. Arsenic levels in fingernails as a biological indicator of exposure to arsenic. Am Ind Hyg Assoc J 1990;51:646-51.
6. Buchet JP, Lauwerys R, Roels H. Comparison of the urinary excretion of arsenic metabolites after a single dose of sodium arsenite, monomethylarsonate or dimethylarsinate in man. Int Arch Occup Environ Health 1981;48:71-9.
7. Biggs ML, Kalman DA, Moore LE, Hopenhayn-Rich C, Smith MT, Smith AH. Relationship of urinary arsenic to intake estimates and a biomarker of effect, bladder cell micronuclei. Mutat Res 1997;386:185-95.
8. Liou SH, Lung JC, Chen YH, Yang T, Hsieh LL, Chen CJ, Wu TN. Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area. Cancer Res 1999;59:1481-4.
9. National Research Council. Arsenic in drinking water. Washington, DC: National Academy Press, 1999;193-228.
10. Ostrosky-Wegman P, Gonsebatt ME, Montero R, Vega L, Barba H, Espinosa J. Lymphocyte proliferation kinetics and genotoxic findings in a pilot study on individuals chronically exposed to arsenic in Mexico. Mutat Res 1991;250:477-82.
11. Maki-Paakkanen J, Kurttio P, Paldy A, Pekkanen J. Association between the clastogenic effect in peripheral lymphocytes and human exposure to arsenic through drinking water. Environ Mol Mutagen 1998;32:301-13.
12. Dulout FN, Grillo CA, Seoane AI, Maderna CR, Nilsson R, Vahter M, Darroudi F, Natarajan AT. Chromosomal aberrations in peripheral blood lymphocytes from native Andean women and children from northwestern Argentina exposed to arsenic in drinking water. Mutat Res 1996;370:151-8.
13. Basu A, Mahata J, Gupta S, Giri AK. Genetic toxicology of a paradoxical human carcinogen, arsenic-a review. Mutat Res 2001;488:171-94.
14. Basu A, Mahata J, Roy AK, Sarkar JN, Poddar G, Nandy AK, Sarkar PK, Dutta PK, Banerjee A, Das M, Ray K, Roychaudhury S, et al. Enhanced frequency of micronuclei in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat Res 2002;516:29-40.
15. Mahata J, Basu A, Ghoshal S, Sarkar JN, Roy AK, Poddar G, Nandy AK, Banerjee A, Ray K, Natarajan AT, Nilsson R, Giri AK. Chromosomal aberrations and sister chromatid exchanges in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat Res 2003;534:133-43.
16. Basu A, Ghosh P, Das JK, Banerjee A, Ray K, Giri AK. Micronuclei as biomarkers of carcinogen exposure in populations exposed to arsenic through drinking water in West Bengal, India: a comparative study in 3 cell types. Cancer Epidemiol Biomarkers Prev 2004;13:820-7.
17. Chowdhury TR, Mondal BK, Samanta G, Basu GK, Chowdhury PP, Chanda R, Karan NK, Lodh D, Dhar RK, Das D, Saha KC, Chakraborti D. Arsenic in groundwater in six districts of West Bengal, India: the biggest calamity in the world: the status report up to August 1995. In: Abernathy CO, Calderon RL, Chappell WR. eds.Arsenic exposure and health effects. London: Chapman and Hall, 1997. vol.9,93-111.
18. Vahter M, Concha G, Nermel B, Nilsson R, Dulout F, Natarajan AT. A unique metabolism of inorganic arsenic in native Andean women. Eur J Pharm 1995;293:455-62.
19. Abernathy CO, Liu YP, Longfellow D, Aposhian HV, Beck B, Fowler B, Goyer R, Menzer R, Rossman T, Thompson C, Waalkes M. Arsenic: health effects, mechanism of actions and research issues. Environ Health Perspect 1999;107:593-7.
20. Hopenhayn-Rich C, Browning SR, Picciotto IH, Ferreccio C, Peralta C, Gibb H. Chronic arsenic exposure and risk of infant mortality in two areas of Chile. Environ Health Perspect 2000;108:667-73.
21. Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione-S- transferase family of enzymes. Mutat Res 2001;482:21-6.
22. Ketterer B, Meyer DJ, Taylor JB, Pemble S, Coles B, Fraser G. GSTs and protection against oxidative stress. In: Hayes JD, Pickett CB, Mantle TJ, eds. Glutathione S-transferase and drug resistance. London: Taylor and Frances, 1990.97-109.
23. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445-600.
24. Strange RC, Fryer AA. The glutathione S-transferases: influence of polymorphism on cancer susceptibility. IARC Sci Publ 1999;148:231-49.
25. Andonova IE, Sarueva RB, Horvath AD, Simeonov VA, Dimitrov PS, Petropoulos EA, Ganev VS. Balkan endemic neuropathy and genetic variants of glutathione S-transferases. J Nephrol 2004;17:390-8.
26. Engel LS, Taioli E, Pfeiffer R, Garcia-Closas M, Marcus PM, Lan Q, Boffetta P, Vineis P, Autrup H, Bell DA, Branch RA, Brockmoller J, et al. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol 2002;156:95-109.
27. Cotton SC, Sharp L, Little J, Brockton N. Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol 2000;151:7-32.
28. Lu XM, Zhang YM, Lin RY, Arzi G, Wang X, Zhang YL, Zhang Y, Wang Y, Wen H. Relationship between genetic polymorphisms of metabolizing enzymes CYP2E1, GSTM1 and Kazakh's esophageal squamous cell cancer in Xinjiang, China. World J Gastroenterol 2005;11:3651-4.
29. Chen H, Sandler DP, Taylor JA, Shore DL, Liu E, Bloomfield CD, Bell DA. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase θ 1 (GSTT1) gene defect. Lancet 1996;347:295-7.
30. Kelsey KT, Wrensch M, Zuo ZF, Miike R, Wiencke JK. A population-based case-control study of the CYP2D6 and GSTT1 polymorphisms and malignant brain tumors. Pharmacogenetics 1997;7:463-8.
31. Terrier P, Townsend AJ, Coindre JM, Triche TJ, Cowan KH. An immunohistochemical study of Φ class glutathione S-transferase expression in normal human tissue. Am J Pathol 1990;137:845-53.
32. Sundberg AG, Nilsson R, Appelkvist EL, Dallner G. Immunohistochemical localization of α and Φ class glutathione transferases in normal human tissues. Pharmacol Toxicol 1993;72:321-31.
33. Setiawan VW, Zhang ZF, Yu GP, Lu QY, Li YL, Lu ML, Wang MR, Guo CH, Yu SZ, Kurtz RC, Hsieh CC. GSTP1 polymorphisms and gastric cancer in a high-risk Chinese population. Cancer Causes Control 2001;12:673-81.
34. Berhane K, Widersten M, Engstrom A, Kozarich JW, Mannervik B. Detoxication of base propenals and other α, β-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. Proc Natl Acad Sci 1994;91:1480-4.
35. Wang J, Deng Y, Cheng J, Ding J, Tokudome S. GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population. Cancer Lett 2003;201:185-93.
36. Miller DP, Neuberg D, de Vivo I, Wain JC, Lynch TJ, Su L, Christiani DC. Smoking and the risk of lung cancer: susceptibility with GSTP1 polymorphisms. Epidemiology 2003;14:545-51.
37. Mandai BK, Roy Chowdhury T, Samanta G, Basu GK, Chowdhury PP, Chanda CR, Lodh D, Karan NK, Dhar RK, Tamili DK, Das D, Saha KC, et al. Arsenic in ground water in seven districts of West Bengal, India-the biggest arsenic calamity in the world. Curr Sci 1996;70:976-86.
38. Chatterjee A, Das D, Mandai BK, Roy Chowdhury T, Samanta G, Chakraborti D. Arsenic in ground water in six districts of West Bengal, India: the biggest arsenic calamity in the world I. Arsenic species in drinking water and urine of the affected people. Analyst 1995;120:643-50.
39. Das D, Chatterjee A, Mandai BK, Samanta G, Chakraborti D. Arsenic in groundwater in six districts of West Bengal, India: the biggest arsenic calamity in the world. II. Arsenic concentration in drinking water, hair, nails, urine, skin-scale and liver tissue (biopsy) of the affected people. Analyst 1995;120:917-24.
40. Titenko-Holland N, Moore LE, Smith MT. Measurement and characterization of micronuclei in exfoliated human cells by fluorescence in situ hybridization with a centromeric probe. Mutat Res 1994;312:39-50.
41. van Delft JH, Steenwinkel MS, van Asten JG, de Vogel N, Bruijntjes-Rozier TC, Schouten T, Cramers P, Maas L, van Herwijnen MH, van Schooten F, Hopmans PM. Biological monitoring the exposure to polycyclic aromatic hydrocarbons of coke oven workers in relation to smoking and genetic polymorphisms for GSTM1 and GSTT1. Ann Occup Hyg 2001;45:395-408.
42. Jen MH, Hwang JJ, Yang JY, Nabyvanets YB, Hsieh WA, Tsai MH, Quo SD, Chang WP. Micronuclei and nuclear anomalies in urinary exfoliated cells of subjects in radionuclide-contaminated regions. Mutat Res 2002;520:39-46.
43. Tolbert PE, Shy CM, Allen JW. Micronuclei and other nuclear anomalies in buccal smears: methods development. Mutat Res 1992;271:69-77.
44. Reali D, Marino FD, Bahramandpour S, Carducci A, Barale R, Loprieno N. Micronuclei in exfoliated cells and urine mutagenicity in smokers. Mutat Res 1987;192:145-9.
45. Martelli A, Robbiano L, Cosso M, Perrone C, Tagliazucchi A, Giuliano L, Aresca GF, Brambilla G. Comparison of micronuclei frequencies in mono-, bi- and poly-nucleated lymphocytes from subjects of a residential suburb and subjects living near a metallurgical plant. Mutat Res 2000;470:211-19.
46. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbour Press, 1989.
47. Tondel M, Rahman M, Magnuson A, Chowdhury IA, Faruquee MH, Ahmad SA. The relationship of arsenic levels in drinking water and the prevalence rate of skin lesions in Bangladesh. Environ Health Perspect 1999;107:727-9.
48. Haque R, Mazumder DN, Samanta S, Ghosh N, Kalman D, Smith MM, Mitra S, Santra A, Lahiri S, Das S, De BK, Smith AH. Arsenic in drinking water and skin lesions: dose-response data from West Bengal, India. Epidemiology 2003;14:174-82.
49. Gonsebatt ME, Vega L, Montera R, Garcia-Vargas G, Del Razo LM, Albores A, Cebrian ME, Ostrosky-Wegman P. Lymphocyte replicating ability in individuals exposed to arsenic via drinking water. Mutat Res 1994;313:293-9.
50. Lerda D. Sister chromatid exchange (SCE) among individuals chronically exposed to arsenic in drinking water. Mutat Res 1994;312:111-20.
51. Gonsebatt ME, Vega L, Salazar AM, Montero R, Guzman P, Bias J, Del Razo LM, Garcia-Vargas G, Albores A, Cebrian ME, Kelsh M, Ostrosky-Wegman P. Cytogenetic effects in human exposure to arsenic. Mutat Res 1997;386:219-28.
52. Juronen E, Tasa G, Veromann S, Parts L, Tiidla A, Pulges R, Panov A, Soovere L, Koka K, Mikelsaar AV. Polymorphic glutathione S-transferase M1 is a risk factor of primary open-angle glaucoma among Estonians. Exp Eye Res 2000;71:34-9.
53. Verlaan M, te Morsche RHM, Roelofs HMJ, Laheij RJF, Jansen JBMJ, Peters WHM, Drenth JPH. Glutathione S-transferase μ null genotype affords protection against alcohol induced chronic pancreatitis. Am J Med Genet A 2003;120:34-9.
54. Lewis SJ, Cherry NM, Niven Robert McL, Barber PV, Povey AC. GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risk. Cancer Lett 2002;180:165-71.
55. Guenrich FP, Their R, Persmark M, Taylor JB, Pemble SE, Ketterer B. Conjugation of carcinogens by θ class glutathione S-transferase: mechanisms and relevance to variations in human risk. Pharmacogenetics 1995;5:S103-7.
56. Sherratt PJ, Pulford DJ, Harrison DJ, Green T, Hayes JD. Evidence that human class θ glutathione S-transferase T1-1 can catalyse the activation of dichloromethane, a liver and lung carcinogen in the mouse. Comparison of the tissue distribution of GST T1-1 with that of classes α, μ and Φ GST in human. Biochem J 1997;326:837-46.
57. van Bladeren PJ. Glutathione conjugation as a bioactivation reaction. Chem Biol Interact 2000;129:61-76.